Patent details

EP2136801 Title: KAPPA-OPIATE AGONISTS FOR THE TREATMENT OF DIARRHEA-PREDOMINANT AND ALTERNATING IRRITABLE BOWEL SYNDROME

Basic Information

Publication number:
EP2136801
PCT Application Number:
PCT/US/2008/056317
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087317483
PCT Publication Number:
WO/2008/121496
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
KAPPA-OPIATE AGONISTS FOR THE TREATMENT OF DIARRHEA-PREDOMINANT AND ALTERNATING IRRITABLE BOWEL SYNDROME
French Title of Invention:
AGONISTES DU RÉCEPTEUR OPIACÉ KAPPA POUR LE TRAITEMENT DU SYNDROME DU CÔLON IRRITABLE AVEC ALTERNANCE OU À DIARRHÉE PRÉDOMINANTE
German Title of Invention:
KAPPA-OPIAT-AGONISTEN ZUR BEHANDLUNG DES DIARRHÖ-DOMINANTEN UND ABWECHSELNDEN REIZDARMSYNDROMS
SPC Number:

Dates

Filing date:
07/03/2008
Grant date:
29/08/2012
EP Publication Date:
29/08/2012
PCT Publication Date:
09/10/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/12/2009
EP B1 Publication Date:
29/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/03/2015
Expiration date:
07/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/03/2008
 
 

Name:
Tioga Pharmaceuticals Inc.
Address:
9393 Towne Centre Dr., Suite 200, San Diego, CA 92121, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
27/09/2012
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
MANGEL Allen
Address:
United States (US)

Priority

Priority Number:
920841 P
Priority Date:
30/03/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4015;
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56